Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology modelMelissa L P Price, Wayne C Guida, Tara E Jackson, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.Journal of Medicinal Chemistry|December 22, 2006
Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylaseAmy L Allan, Patricia L Gladstone, Melissa L P Price, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modificationsBrett R Ullman, Teresa Aja, Thomas L Deckwerth, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.Pageof 1